Lung cancer is commonly perceived to be a smokers’ disease that affects the elderly, but the disease also affects younger ex-smokers and even those who have never smoked. This misconception can be a barrier to early diagnosis and effective treatment.
To increase awareness and understanding of this complex disease, and help drive improved outcomes for patients, we are sharing the different experiences and perspectives that people have of lung cancer and the impact it has on people’s lives.
Like any serious illness, lung cancer has a far-reaching impact, not only on the patient diagnosed and going through treatment, but also on their caregivers and families.
Understanding lung cancers and what drives them is hugely important for doctors in determining the best treatment for patients.
We recognise that many people do not like to talk about lung cancer due to the stigma associated with the disease.
Dramatic advancements in the understanding of lung cancer over the years have led to better outcomes for patients.
Greater understanding of subtypes and how different gene fusions or rearrangements drive cancer cell growth and survival has allowed for the development of new tests and treatments for lung cancer and has transformed the patient journey.
Whether testing for PD-L1 to enable treatment with immunotherapies, or testing for gene fusions, such as ALK, EGFR or ROS1, to allow treatment with a specific targeted therapy, continued research and a holistic approach to lung cancer diagnosis and treatment is core to providing effective options for every person diagnosed with the disease.
World Health Organization. Cancer. [Internet; cited October 2019]. Available from:
World Health Organization. GLOBOCAN 2018; Lung Cancer: Estimated cancer incidence, mortality and prevalence worldwide. [Internet cited October 2019] Available from:
Cancer Research UK. Worldwide Cancer Statistics. [Internet; cited October 2019]
American Cancer Society. What Is Non-Small Cell Lung Cancer? [Internet; cited October 2019]. Available from:
MedicineNet. Non-Small Cell Lung Cancer vs. Small Cell Lung Cancer. [Internet; cited October 2019]. Available from:
Jain P et al. Role of immune-checkpoint inhibitors in lung cancer. Ther Adv Respir Dis. 2018:12;1753465817750075.
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.